000			01764 a2200541 4500
005			20250514005825.0
264		0	_c20010913
008			200109s 0 0 eng d
022			_a0008-5472
040			_aNLM _beng _cNLM
100	1		_aLi, Y
245	0	0	_aA hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. _h[electronic resource]
260			_bCancer research _cSep 2001
300			_a6428-36 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdenoviridae _xgenetics
650	0	4	_aAdenovirus E1A Proteins _xgenetics
650	0	4	_aAdenovirus E1B Proteins _xgenetics
650	0	4	_aAdenovirus E3 Proteins _xgenetics
650	0	4	_aAnimals
650	0	4	_aAntibiotics, Antineoplastic _xpharmacology
650	0	4	_aCarcinoma, Hepatocellular _xdrug therapy
650	0	4	_aCombined Modality Therapy
650	0	4	_aCytopathogenic Effect, Viral
650	0	4	_aDoxorubicin _xpharmacology
650	0	4	_aGenetic Vectors
650	0	4	_aHumans
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Nude
650	0	4	_aProstatic Neoplasms _xdrug therapy
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aResponse Elements _xgenetics
650	0	4	_aRibosomes _xgenetics
650	0	4	_aTumor Cells, Cultured
650	0	4	_aVirus Replication
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_aalpha-Fetoproteins _xbiosynthesis
700	1		_aYu, D C
700	1		_aChen, Y
700	1		_aAmin, P
700	1		_aZhang, H
700	1		_aNguyen, N
700	1		_aHenderson, D R
773	0		_tCancer research _gvol. 61 _gno. 17 _gp. 6428-36
999			_c11446923 _d11446923